Healthcare Sector Stocks
The Healthcare sector has a total of 1052 stocks, with a combined market cap of $9.4 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 49.88.
Market Cap
9.4T
Revenue
4.67T
Profits
188.44B
PE Ratio
49.88
Profit Margin
4.04%
Dividend Yield
0.39%
1051 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.11T | -1.33% | 1,960,328 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 611.61B | -0.69% | 8,852,862 | 99.34B |
| 3 | ABBV | AbbVie Inc. | 499.53B | -0.96% | 4,175,122 | 64.39B |
| 4 | UNH | UnitedHealth Group Incorporated | 365.21B | 1.36% | 4,999,988 | 450.06B |
| 5 | MRK | Merck & Co., Inc. | 354.36B | -1.59% | 10,448,544 | 66.57B |
| 6 | NVS | Novartis AG | 285.89B | -0.28% | 1,866,733 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 256.17B | -0.88% | 2,322,146 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 251.20B | -1.54% | 2,403,818 | 46.34B |
| 9 | AMGN | Amgen Inc. | 229.74B | -1.75% | 2,682,814 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 189.80B | -2.00% | 6,832,947 | 30.46B |
| 11 | ABT | Abbott Laboratories | 180.06B | -0.79% | 8,044,990 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 170.32B | -1.06% | 7,452,515 | 50.34B |
| 13 | PFE | Pfizer Inc. | 167.80B | -0.47% | 20,816,618 | 63.70B |
| 14 | DHR | Danaher Corporation | 157.77B | -2.01% | 4,139,472 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 153.03B | 1.52% | 2,553,388 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 127.22B | 0.44% | 1,298,660 | 12.59B |
| 17 | BMY | Bristol-Myers Squibb Company | 120.17B | -1.54% | 11,551,825 | 49.19B |
| 18 | CVS | CVS Health Corporation | 118.53B | 0.35% | 5,377,291 | 412.65B |
| 19 | MCK | McKesson Corporation | 117.81B | 0.56% | 757,170 | 410.98B |
| 20 | SYK | Stryker Corporation | 114.28B | 1.11% | 3,064,550 | 25.84B |
| 21 | MDT | Medtronic plc | 113.56B | -2.09% | 23,012,074 | 37.54B |
| 22 | GSK | GSK plc | 99.00B | -0.10% | 5,373,016 | 44.05B |
| 23 | HCA | HCA Healthcare, Inc. | 98.48B | -0.86% | 918,311 | 78.01B |
| 24 | SNY | Sanofi | 95.49B | -2.56% | 3,615,120 | 55.89B |
| 25 | ELV | Elevance Health, Inc. | 93.30B | 0.46% | 998,321 | 201.11B |
| 26 | MRNA | Moderna, Inc. | 90.58B | 4.07% | 18,858,488 | 2.23B |
| 27 | CI | The Cigna Group | 78.88B | -1.26% | 1,228,752 | 282.38B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 78.09B | -1.10% | 489,284 | 15.53B |
| 29 | BSX | Boston Scientific Corporation | 65.29B | 1.49% | 14,116,032 | 21.00B |
| 30 | COR | Cencora, Inc. | 64.88B | -0.27% | 1,031,376 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 62.94B | -0.31% | 2,877,471 | 28.42B |
| 32 | CAH | Cardinal Health, Inc. | 58.50B | -0.55% | 3,781,669 | 254.25B |
| 33 | NTRA | Natera, Inc. | 57.57B | 1.52% | 1,328,347 | 2.71B |
| 34 | BDX | Becton, Dickinson and Company | 51.96B | -0.53% | 1,220,203 | 22.48B |
| 35 | VEEV | Veeva Systems Inc. | 51.29B | 2.08% | 1,381,447 | 3.46B |
| 36 | ARGX | argenx SE | 51.20B | 0.79% | 394,789 | 5.32B |
| 37 | EW | Edwards Lifesciences Corporation | 50.27B | 0.72% | 2,764,629 | 6.51B |
| 38 | HUM | Humana Inc. | 49.83B | 0.44% | 1,381,806 | 145.68B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 48.14B | -0.46% | 3,827,985 | 17.32B |
| 40 | A | Agilent Technologies, Inc. | 47.90B | -1.77% | 2,474,633 | 7.37B |
| 41 | MDLN | Medline Inc. | 46.26B | -2.14% | 7,697,313 | 29.94B |
| 42 | HLN | Haleon plc | 44.23B | 0.10% | 20,191,421 | 14.80B |
| 43 | IDXX | IDEXX Laboratories, Inc. | 43.79B | -0.81% | 497,085 | 4.55B |
| 44 | IQV | IQVIA Holdings Inc. | 43.76B | -0.38% | 834,975 | 16.98B |
| 45 | WAT | Waters Corporation | 42.67B | -0.61% | 468,853 | 4.64B |
| 46 | ONC | BeOne Medicines AG | 42.09B | 0.30% | 289,674 | 6.13B |
| 47 | ILMN | Illumina, Inc. | 39.66B | 0.05% | 1,902,236 | 4.49B |
| 48 | RVMD | Revolution Medicines, Inc. | 39.04B | 2.35% | 1,978,403 | - |
| 49 | RPRX | Royalty Pharma plc | 34.66B | -1.13% | 2,813,221 | 2.54B |
| 50 | BIIB | Biogen Inc. | 34.50B | 0.36% | 949,587 | 10.03B |
| 51 | CNC | Centene Corporation | 33.90B | -0.77% | 3,373,939 | 180.30B |
| 52 | RMD | ResMed Inc. | 33.72B | 0.33% | 932,190 | 5.65B |
| 53 | ZTS | Zoetis Inc. | 32.89B | 0.26% | 3,064,795 | 9.53B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.57B | 0.21% | 135,789 | 4.13B |
| 55 | DXCM | DexCom, Inc. | 32.45B | -0.07% | 2,590,221 | 4.97B |
| 56 | ALC | Alcon Inc. | 31.94B | -0.08% | 1,099,991 | 10.86B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 31.51B | 0.27% | 2,278,225 | 21.27B |
| 58 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.22B | 0.63% | 1,344,464 | 4.80B |
| 59 | WST | West Pharmaceutical Services, Inc. | 27.02B | -0.03% | 312,775 | 3.33B |
| 60 | DGX | Quest Diagnostics Incorporated | 25.93B | -0.04% | 864,648 | 11.56B |
| 61 | LH | Labcorp Holdings Inc. | 25.86B | 0.28% | 650,191 | 14.35B |
| 62 | PHG | Koninklijke Philips N.V. | 25.12B | -0.93% | 1,114,616 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 25.06B | 3.49% | 6,333,708 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.30B | 1.88% | 498,293 | 3.15B |
| 65 | INCY | Incyte Corporation | 22.96B | 0.16% | 1,190,052 | 5.82B |
| 66 | GMAB | Genmab A/S | 22.80B | 4.05% | 4,773,437 | 4.13B |
| 67 | BNTX | BioNTech SE | 22.41B | 1.71% | 1,342,645 | 3.03B |
| 68 | STE | STERIS plc | 21.64B | -0.31% | 477,397 | 6.04B |
| 69 | THC | Tenet Healthcare Corporation | 21.45B | -0.32% | 499,584 | 21.81B |
| 70 | GH | Guardant Health, Inc. | 21.19B | -0.45% | 1,869,506 | 1.18B |
| 71 | VTRS | Viatris Inc. | 20.97B | -2.14% | 11,529,185 | 14.74B |
| 72 | INSM | Insmed Incorporated | 20.81B | -1.02% | 2,723,440 | 1.14B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 18.12B | 0.01% | 1,150,758 | 8.51B |
| 74 | MEDP | Medpace Holdings, Inc. | 17.30B | 0.19% | 247,060 | 2.78B |
| 75 | RVTY | Revvity, Inc. | 16.84B | -1.11% | 1,259,525 | 2.91B |
| 76 | EXEL | Exelixis, Inc. | 15.53B | 0.72% | 1,934,073 | 2.44B |
| 77 | ASND | Ascendis Pharma A/S | 15.10B | 2.09% | 1,268,039 | 1.20B |
| 78 | SOLV | Solventum Corporation | 14.48B | -0.89% | 850,961 | 8.31B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.32B | -0.04% | 506,629 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.92B | 0.94% | 1,050,277 | 3.37B |
| 81 | HALO | Halozyme Therapeutics, Inc. | 13.90B | 0.54% | 1,899,171 | 1.66B |
| 82 | JAZZ | Jazz Pharmaceuticals plc | 13.53B | -0.86% | 716,916 | 4.60B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.28B | 2.33% | 2,292,327 | 713.07M |
| 84 | ICLR | ICON Public Limited Company | 12.98B | -1.18% | 728,519 | 8.29B |
| 85 | BAX | Baxter International Inc. | 12.92B | -1.15% | 5,345,848 | 11.47B |
| 86 | BTSG | BrightSpring Health Services, Inc. | 12.77B | 0.69% | 1,268,948 | 14.37B |
| 87 | PEN | Penumbra, Inc. | 12.70B | 0.48% | 272,594 | 1.50B |
| 88 | SMMT | Summit Therapeutics Inc. | 12.45B | 6.43% | 6,151,415 | - |
| 89 | CORT | Corcept Therapeutics Incorporated | 12.12B | 1.76% | 392,843 | 830.81M |
| 90 | SNN | Smith & Nephew plc | 12.03B | -0.76% | 635,030 | 6.30B |
| 91 | EHC | Encompass Health Corporation | 12.01B | -4.82% | 2,264,695 | 6.21B |
| 92 | DVA | DaVita Inc. | 11.93B | -0.17% | 325,522 | 14.01B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.74B | -0.25% | 2,900,356 | 5.02B |
| 94 | TEM | Tempus AI, Inc. | 11.61B | -0.59% | 4,165,194 | 1.43B |
| 95 | FMS | Fresenius Medical Care AG | 11.61B | -1.04% | 562,843 | 22.19B |
| 96 | TECH | Bio-Techne Corporation | 11.37B | -0.11% | 2,573,895 | 1.22B |
| 97 | COO | The Cooper Companies, Inc. | 11.06B | 0.38% | 2,676,858 | 4.24B |
| 98 | AVTR | Avantor, Inc. | 11.02B | -0.79% | 9,314,072 | 6.56B |
| 99 | MOH | Molina Healthcare, Inc. | 10.95B | 1.37% | 578,262 | 42.47B |
| 100 | RDY | Dr. Reddy's Laboratories Limited | 10.91B | 0.08% | 1,499,344 | 3.50B |
| 101 | UHS | Universal Health Services, Inc. | 10.74B | -1.52% | 547,644 | 18.11B |
| 102 | ALGN | Align Technology, Inc. | 10.58B | 1.15% | 771,184 | 4.14B |
| 103 | BMRN | BioMarin Pharmaceutical Inc. | 10.58B | -0.02% | 2,995,128 | 3.41B |
| 104 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.33B | -0.59% | 263,725 | 1.28B |
| 105 | GMED | Globus Medical, Inc. | 10.16B | -1.38% | 1,260,516 | 3.14B |
| 106 | OSCR | Oscar Health, Inc. | 10.03B | 2.04% | 3,468,771 | 15.32B |
| 107 | PCVX | Vaxcyte, Inc. | 10.02B | 0.09% | 2,548,907 | - |
| 108 | ENSG | The Ensign Group, Inc. | 10.00B | -2.03% | 273,515 | 5.49B |
| 109 | RGEN | Repligen Corporation | 9.96B | 0.58% | 769,057 | 785.10M |
| 110 | PODD | Insulet Corporation | 9.85B | 0.61% | 2,305,694 | 3.05B |
| 111 | GKOS | Glaukos Corporation | 9.84B | 1.29% | 775,393 | 612.84M |
| 112 | QGEN | Qiagen N.V. | 9.63B | 0.91% | 2,159,800 | 2.10B |
| 113 | KRYS | Krystal Biotech, Inc. | 9.48B | 1.16% | 207,680 | 440.48M |
| 114 | BIO | Bio-Rad Laboratories, Inc. | 9.43B | -0.25% | 220,836 | 2.59B |
| 115 | HSIC | Henry Schein, Inc. | 9.36B | -2.79% | 1,317,231 | 13.60B |
| 116 | TXG | 10x Genomics, Inc. | 9.11B | 0.04% | 2,521,963 | 616.91M |
| 117 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 3.14% | 683,118 | 105.00M |
| 118 | IBRX | ImmunityBio, Inc. | 8.92B | -8.28% | 19,562,081 | 165.79M |
| 119 | TWST | Twist Bioscience Corporation | 8.76B | 5.29% | 1,590,350 | 431.80M |
| 120 | CYTK | Cytokinetics, Incorporated | 8.71B | 1.13% | 1,912,762 | 67.67M |
| 121 | PTGX | Protagonist Therapeutics, Inc. | 8.70B | 4.42% | 654,153 | 281.99M |
| 122 | CAI | Caris Life Sciences, Inc. | 8.68B | 0.49% | 2,101,391 | 989.61M |
| 123 | BRKR | Bruker Corporation | 8.44B | 1.04% | 1,911,873 | 3.50B |
| 124 | HNGE | Hinge Health, Inc. | 8.39B | 4.84% | 1,236,830 | 720.06M |
| 125 | AXSM | Axsome Therapeutics, Inc. | 8.16B | -0.85% | 781,729 | 776.57M |
| 126 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.08B | 2.38% | 1,646,664 | 669.50M |
| 127 | ATR | AptarGroup, Inc. | 7.92B | 0.10% | 277,481 | 3.93B |
| 128 | SYRE | Spyre Therapeutics, Inc. | 7.92B | 6.03% | 1,272,029 | - |
| 129 | HQY | HealthEquity, Inc. | 7.70B | 1.13% | 532,931 | 1.36B |
| 130 | ABVX | ABIVAX Société Anonyme | 7.62B | -0.73% | 1,573,332 | 5.33M |
| 131 | TGTX | TG Therapeutics, Inc. | 7.56B | -1.24% | 1,545,965 | 799.54M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.38B | 3.35% | 3,109,987 | 874.09M |
| 133 | PRAX | Praxis Precision Medicines, Inc. | 7.26B | 7.61% | 860,757 | 7.46M |
| 134 | PACS | PACS Group, Inc. | 7.26B | -2.26% | 620,972 | 5.55B |
| 135 | ALKS | Alkermes plc | 7.21B | 4.25% | 2,791,708 | 1.67B |
| 136 | GRFS | Grifols, S.A. | 6.76B | - | 1,464,114 | 8.48B |
| 137 | AMRX | Amneal Pharmaceuticals, Inc. | 6.74B | 0.94% | 2,098,603 | 3.12B |
| 138 | CHE | Chemed Corporation | 6.62B | -0.80% | 97,229 | 2.60B |
| 139 | HIMS | Hims & Hers Health, Inc. | 6.57B | 0.29% | 7,486,389 | 2.58B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.52B | 0.22% | 2,174,521 | 1.56B |
| 141 | IOVA | Iovance Biotherapeutics, Inc. | 6.44B | 4.33% | 8,503,802 | 324.97M |
| 142 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.20B | 1.13% | 602,129 | 840.85M |
| 143 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.07B | 2.39% | 378,773 | 239.92M |
| 144 | BLTE | Belite Bio, Inc | 5.93B | 3.19% | 164,377 | - |
| 145 | BLCO | Bausch + Lomb Corporation | 5.93B | 0.73% | 357,031 | 5.32B |
| 146 | LGND | Ligand Pharmaceuticals Incorporated | 5.93B | 0.59% | 116,959 | 290.54M |
| 147 | KOD | Kodiak Sciences Inc. | 5.73B | 6.53% | 1,047,418 | - |
| 148 | IMVT | Immunovant, Inc. | 5.70B | 3.33% | 1,374,296 | - |
| 149 | DOCS | Doximity, Inc. | 5.61B | 1.55% | 2,027,872 | 655.57M |
| 150 | TFX | Teleflex Incorporated | 5.49B | -0.58% | 770,129 | 2.25B |
| 151 | GRAL | GRAIL, Inc. | 5.47B | 3.91% | 577,686 | 165.26M |
| 152 | RDNT | RadNet, Inc. | 5.45B | 0.68% | 341,993 | 2.27B |
| 153 | HAE | Haemonetics Corporation | 5.40B | 0.38% | 392,213 | 1.35B |
| 154 | MMSI | Merit Medical Systems, Inc. | 5.37B | 0.85% | 580,950 | 1.58B |
| 155 | WAY | Waystar Holding Corp. | 5.37B | 2.30% | 2,093,626 | 1.21B |
| 156 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | 2.62% | 417,851 | 618.07M |
| 157 | CGON | CG Oncology, Inc. | 5.32B | 0.22% | 1,215,066 | 6.23M |
| 158 | COGT | Cogent Biosciences, Inc. | 5.21B | 1.66% | 2,541,147 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.19B | 0.63% | 560,380 | 1.40B |
| 160 | PTCT | PTC Therapeutics, Inc. | 5.14B | 3.87% | 942,774 | 1.01B |
| 161 | MANE | Veradermics, Incorporated | 5.11B | 12.37% | 1,465,873 | - |
| 162 | SHC | Sotera Health Company | 5.03B | -1.40% | 1,612,150 | 1.22B |
| 163 | MMED | MiniMed Group, Inc. | 5.01B | 1.72% | 17,459,177 | 3.22B |
| 164 | RGC | Regencell Bioscience Holdings Limited | 4.98B | 4.80% | 834,117 | - |
| 165 | ORKA | Oruka Therapeutics, Inc. | 4.93B | 3.55% | 816,393 | - |
| 166 | SRRK | Scholar Rock Holding Corporation | 4.90B | 0.85% | 1,480,015 | - |
| 167 | CON | Concentra Group Holdings Parent, Inc. | 4.87B | -0.93% | 976,304 | 2.29B |
| 168 | CRSP | CRISPR Therapeutics AG | 4.84B | 1.60% | 1,171,640 | 13.39M |
| 169 | BLLN | BillionToOne, Inc. | 4.77B | 2.97% | 462,614 | 397.41M |
| 170 | ERAS | Erasca, Inc. | 4.76B | 1.72% | 4,263,873 | - |
| 171 | TVTX | Travere Therapeutics, Inc. | 4.76B | 1.79% | 1,311,809 | 591.33M |
| 172 | OPCH | Option Care Health, Inc. | 4.67B | 0.03% | 2,967,252 | 5.69B |
| 173 | LFST | LifeStance Health Group, Inc. | 4.50B | 0.26% | 3,652,644 | 1.58B |
| 174 | HTFL | HeartFlow, Inc. | 4.44B | 5.65% | 1,603,553 | 212.07M |
| 175 | DFTX | Definium Therapeutics, Inc. | 4.43B | 2.71% | 1,735,697 | - |
| 176 | ITGR | Integer Holdings Corporation | 4.31B | 0.04% | 478,644 | 1.84B |
| 177 | LIVN | LivaNova PLC | 4.31B | 0.72% | 387,098 | 1.47B |
| 178 | DNTH | Dianthus Therapeutics, Inc. | 4.17B | 3.54% | 972,522 | 1.90M |
| 179 | EWTX | Edgewise Therapeutics, Inc. | 4.12B | 1.96% | 1,421,563 | - |
| 180 | ICUI | ICU Medical, Inc. | 4.03B | -1.01% | 153,808 | 2.16B |
| 181 | ARQT | Arcutis Biotherapeutics, Inc. | 4.01B | 10.65% | 5,795,314 | 463.98M |
| 182 | INDV | Indivior Pharmaceuticals, Inc. | 4.00B | 4.38% | 2,276,265 | 1.33B |
| 183 | TNGX | Tango Therapeutics, Inc. | 3.97B | 6.76% | 1,870,824 | 53.81M |
| 184 | ABCL | AbCellera Biologics Inc. | 3.87B | 1.10% | 3,129,245 | 66.17M |
| 185 | ADPT | Adaptive Biotechnologies Corporation | 3.82B | -0.29% | 1,182,301 | 308.08M |
| 186 | NHC | National HealthCare Corporation | 3.75B | -1.47% | 165,399 | 1.56B |
| 187 | RLAY | Relay Therapeutics, Inc. | 3.75B | 4.98% | 1,695,410 | 10.35M |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.66B | 0.47% | 249,783 | 890.79M |
| 189 | NVST | Envista Holdings Corporation | 3.63B | -1.27% | 2,541,049 | 2.86B |
| 190 | LEGN | Legend Biotech Corporation | 3.61B | 0.92% | 1,894,444 | 1.27B |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.61B | 0.87% | 665,864 | 825.34M |
| 192 | OGN | Organon & Co. | 3.61B | -0.07% | 3,253,842 | 6.13B |
| 193 | VCYT | Veracyte, Inc. | 3.52B | 1.58% | 716,885 | 561.90M |
| 194 | CDNA | CareDx, Inc. | 3.47B | 4.81% | 990,002 | 458.09M |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.43B | 3.76% | 1,380,850 | -665.00K |
| 196 | ACAD | Acadia Pharmaceuticals Inc. | 3.41B | 3.56% | 1,298,611 | 1.14B |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.40B | 4.75% | 1,188,665 | 7.50M |
| 198 | PLSE | Pulse Biosciences, Inc. | 3.39B | 7.02% | 342,348 | 1.19M |
| 199 | IDYA | IDEAYA Biosciences, Inc. | 3.26B | 2.92% | 765,766 | 234.13M |
| 200 | PBLS | Parabilis Medicines, Inc. | 3.13B | 11.43% | 2,136,774 | 148.00K |
| 201 | WRBY | Warby Parker Inc. | 3.09B | 7.07% | 4,401,383 | 911.61M |
| 202 | LQDA | Liquidia Corporation | 3.05B | -0.64% | 3,025,099 | 450.91M |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.05B | 2.10% | 682,545 | 606.33M |
| 204 | IRON | Disc Medicine, Inc. | 3.03B | 38.86% | 8,460,170 | - |
| 205 | VKTX | Viking Therapeutics, Inc. | 2.92B | -0.48% | 3,731,850 | - |
| 206 | DNLI | Denali Therapeutics Inc. | 2.88B | 2.44% | 2,686,355 | 3.60M |
| 207 | PRVA | Privia Health Group, Inc. | 2.87B | -0.36% | 750,009 | 2.36B |
| 208 | DYN | Dyne Therapeutics, Inc. | 2.84B | 6.88% | 3,346,143 | - |
| 209 | ELVN | Enliven Therapeutics, Inc. | 2.84B | 3.70% | 1,312,162 | - |
| 210 | ATRC | AtriCure, Inc. | 2.82B | -0.96% | 606,912 | 569.62M |
| 211 | RCUS | Arcus Biosciences, Inc. | 2.82B | 0.09% | 3,516,681 | 117.00M |
| 212 | ACHC | Acadia Healthcare Company, Inc. | 2.81B | 0.67% | 996,211 | 3.37B |
| 213 | CELC | Celcuity Inc. | 2.79B | 0.95% | 2,750,585 | - |
| 214 | NRIX | Nurix Therapeutics, Inc. | 2.72B | 2.09% | 3,062,839 | 701.94M |
| 215 | AVAH | Aveanna Healthcare Holdings Inc. | 2.71B | 0.81% | 1,616,715 | 2.60B |
| 216 | ZLAB | Zai Lab Limited | 2.70B | 3.75% | 383,625 | 449.61M |
| 217 | GRDN | Guardian Pharmacy Services, Inc. | 2.54B | 1.70% | 378,646 | 1.46B |
| 218 | NEOG | Neogen Corporation | 2.54B | -1.52% | 3,419,589 | 884.00M |
| 219 | MBX | MBX Biosciences, Inc. | 2.53B | 5.79% | 522,209 | - |
| 220 | HCM | HUTCHMED (China) Limited | 2.51B | 0.71% | 28,369 | 549.12M |
| 221 | TMDX | TransMedics Group, Inc. | 2.48B | 1.16% | 656,739 | 668.47M |
| 222 | ADMA | ADMA Biologics, Inc. | 2.48B | 3.65% | 2,873,626 | 512.28M |
| 223 | NAMS | NewAmsterdam Pharma Company N.V. | 2.45B | 3.23% | 724,162 | 7.12M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.42B | 3.07% | 1,316,241 | 156.04M |
| 225 | PGEN | Precigen, Inc. | 2.38B | 4.23% | 4,139,949 | 85.72M |
| 226 | BHC | Bausch Health Companies Inc. | 2.36B | 0.32% | 1,354,817 | 10.85B |
| 227 | CLOV | Clover Health Investments, Corp. | 2.36B | -0.89% | 3,814,551 | 2.48B |
| 228 | VRDN | Viridian Therapeutics, Inc. | 2.36B | 9.30% | 2,576,139 | 71.13M |
| 229 | PBH | Prestige Consumer Healthcare Inc. | 2.35B | -0.42% | 682,141 | 1.10B |
| 230 | BKD | Brookdale Senior Living Inc. | 2.35B | -2.28% | 5,027,982 | 2.93B |
| 231 | CLDX | Celldex Therapeutics, Inc. | 2.33B | 7.77% | 1,719,329 | 158.00K |
| 232 | SUPN | Supernus Pharmaceuticals, Inc. | 2.32B | 5.17% | 1,509,038 | 830.44M |
| 233 | UFPT | UFP Technologies, Inc. | 2.27B | 0.54% | 98,087 | 631.64M |
| 234 | PRGO | Perrigo Company plc | 2.23B | -3.25% | 2,893,901 | 4.14B |
| 235 | AUPH | Aurinia Pharmaceuticals Inc. | 2.19B | -0.12% | 552,177 | 311.51M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | -1.08% | 1,008,460 | 959.90M |
| 237 | MD | Pediatrix Medical Group, Inc. | 2.17B | -0.29% | 454,768 | 1.95B |
| 238 | RXRX | Recursion Pharmaceuticals, Inc. | 2.16B | 4.18% | 29,944,455 | 54.86M |
| 239 | PGNY | Progyny, Inc. | 2.14B | 3.65% | 781,984 | 1.31B |
| 240 | FTRE | Fortrea Holdings Inc. | 2.13B | -0.31% | 1,652,127 | 2.68B |
| 241 | SLS | SELLAS Life Sciences Group, Inc. | 2.12B | 5.11% | 5,609,701 | - |
| 242 | NEO | NeoGenomics, Inc. | 2.11B | -1.38% | 1,332,243 | 766.30M |
| 243 | ADUS | Addus HomeCare Corporation | 2.11B | -0.61% | 130,356 | 1.48B |
| 244 | PHVS | Pharvaris N.V. | 2.09B | 7.32% | 917,061 | - |
| 245 | VERA | Vera Therapeutics, Inc. | 2.08B | 3.73% | 1,269,095 | - |
| 246 | AGIO | Agios Pharmaceuticals, Inc. | 2.08B | 11.43% | 1,973,617 | 98.34M |
| 247 | AXGN | Axogen, Inc. | 2.07B | 1.79% | 782,520 | 251.17M |
| 248 | VCEL | Vericel Corporation | 2.07B | 0.60% | 334,095 | 306.30M |
| 249 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.06B | 3.59% | 9,774,164 | 940.61M |
| 250 | INSP | Inspire Medical Systems, Inc. | 2.03B | 1.98% | 656,147 | 898.74M |
| 251 | XERS | Xeris Biopharma Holdings, Inc. | 2.00B | 6.21% | 4,343,517 | 335.41M |
| 252 | BFLY | Butterfly Network, Inc. | 1.99B | 3.03% | 2,874,849 | 112.14M |
| 253 | TRLV | Trulieve Cannabis Corp. | 1.98B | 2.70% | 875,657 | 1.14B |
| 254 | WGS | GeneDx Holdings Corp. | 1.98B | 4.21% | 504,944 | 454.43M |
| 255 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.06% | 261,983 | 6.13M |
| 256 | SGRY | Surgery Partners, Inc. | 1.91B | 0.68% | 1,306,414 | 3.37B |
| 257 | IMNM | Immunome, Inc. | 1.90B | 1.82% | 1,139,854 | 4.02M |
| 258 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.37% | 139,632 | 1.13B |
| 259 | ASTH | Astrana Health, Inc. | 1.89B | 0.24% | 300,636 | 3.84B |
| 260 | LMAT | LeMaitre Vascular, Inc. | 1.88B | 1.84% | 248,748 | 262.43M |
| 261 | SRPT | Sarepta Therapeutics, Inc. | 1.87B | 3.68% | 2,329,399 | 1.97B |
| 262 | MLYS | Mineralys Therapeutics, Inc. | 1.85B | 3.05% | 1,119,312 | - |
| 263 | ALMR | Alamar Biosciences, Inc. | 1.83B | 4.03% | 550,688 | 100.42M |
| 264 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | 2.95% | 1,348,537 | 208.78M |
| 265 | ZYME | Zymeworks Inc. | 1.81B | 2.04% | 2,039,871 | 37.13M |
| 266 | ALVO | Alvotech | 1.80B | 0.60% | 907,722 | 494.61M |
| 267 | NVAX | Novavax, Inc. | 1.78B | -3.91% | 6,199,195 | 413.80M |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.77B | 2.21% | 270,926 | - |
| 269 | KMTS | Kestra Medical Technologies, Ltd. | 1.75B | 7.82% | 638,776 | 106.73M |
| 270 | ALHC | Alignment Healthcare, Inc. | 1.74B | 1.45% | 3,587,132 | 4.58B |
| 271 | ZBIO | Zenas BioPharma, Inc. | 1.74B | 7.53% | 696,512 | 1.00M |
| 272 | ESTA | Establishment Labs Holdings Inc. | 1.74B | -1.55% | 349,190 | 245.82M |
| 273 | NVCR | NovoCure Limited | 1.73B | 5.83% | 2,225,025 | 699.19M |
| 274 | SDGR | Schrödinger, Inc. | 1.73B | 2.30% | 1,426,954 | 259.04M |
| 275 | VIR | Vir Biotechnology, Inc. | 1.73B | 2.51% | 1,301,381 | 303.23M |
| 276 | XNCR | Xencor, Inc. | 1.72B | 1.49% | 2,036,621 | 104.97M |
| 277 | BHVN | Biohaven Ltd. | 1.71B | 5.29% | 1,690,877 | - |
| 278 | SEPN | Septerna, Inc. | 1.70B | 0.08% | 410,036 | 98.88M |
| 279 | PSNL | Personalis, Inc. | 1.70B | 1.47% | 3,155,522 | 69.67M |
| 280 | TRVI | Trevi Therapeutics, Inc. | 1.70B | 0.17% | 1,597,793 | - |
| 281 | XRAY | DENTSPLY SIRONA Inc. | 1.68B | -1.75% | 4,082,338 | 3.64B |
| 282 | URGN | UroGen Pharma Ltd. | 1.67B | -1.19% | 1,269,300 | 188.73M |
| 283 | MAZE | Maze Therapeutics, Inc. | 1.65B | 7.88% | 1,295,199 | 20.00M |
| 284 | ARDT | Ardent Health, Inc. | 1.65B | -2.18% | 340,259 | 6.41B |
| 285 | OMCL | Omnicell, Inc. | 1.63B | 1.19% | 424,890 | 1.25B |
| 286 | NTLA | Intellia Therapeutics, Inc. | 1.62B | 1.40% | 3,499,342 | 59.51M |
| 287 | GENB | Generate Biomedicines, Inc. | 1.61B | 3.89% | 673,669 | 26.48M |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.61B | -3.57% | 458,979 | 481.07M |
| 289 | ATEC | Alphatec Holdings, Inc. | 1.61B | -0.48% | 1,575,419 | 815.05M |
| 290 | MESO | Mesoblast Limited | 1.61B | -10.02% | 617,787 | 120.25M |
| 291 | STOK | Stoke Therapeutics, Inc. | 1.60B | 2.69% | 711,014 | 27.59M |
| 292 | PAHC | Phibro Animal Health Corporation | 1.60B | 1.21% | 184,695 | 1.52B |
| 293 | NUVB | Nuvation Bio Inc. | 1.57B | 0.67% | 4,223,372 | 169.90M |
| 294 | GPCR | Structure Therapeutics Inc. | 1.57B | 4.41% | 1,311,242 | - |
| 295 | AMN | AMN Healthcare Services, Inc. | 1.57B | 0.02% | 1,601,522 | 3.43B |
| 296 | BRVE | Braveheart Bio, Inc. | 1.57B | 2.67% | 333,741 | - |
| 297 | ANIP | ANI Pharmaceuticals, Inc. | 1.55B | 0.37% | 253,634 | 978.38M |
| 298 | QURE | uniQure N.V. | 1.54B | 1.93% | 1,381,324 | 18.67M |
| 299 | CMPS | COMPASS Pathways plc | 1.54B | 3.35% | 3,276,338 | - |
| 300 | IMCR | Immunocore Holdings plc | 1.54B | 1.50% | 350,976 | 430.78M |
| 301 | AZTA | Azenta, Inc. | 1.53B | 2.20% | 791,781 | 613.81M |
| 302 | INVA | Innoviva, Inc. | 1.52B | 1.54% | 590,499 | 440.00M |
| 303 | COAG | Hemab Therapeutics Holdings, Inc. | 1.50B | 6.72% | 254,484 | - |
| 304 | AGL | agilon health, inc. | 1.49B | 4.36% | 217,597 | 5.92B |
| 305 | KLRA | Kailera Therapeutics, Inc. | 1.48B | 1.60% | 896,581 | - |
| 306 | RARE | Ultragenyx Pharmaceutical Inc. | 1.48B | 3.65% | 2,984,169 | 717.00M |
| 307 | ANAB | AnaptysBio, Inc. | 1.47B | 5.64% | 467,815 | 106.09M |
| 308 | ABSI | Absci Corporation | 1.47B | 3.52% | 2,760,732 | 1.56M |
| 309 | PCRX | Pacira BioSciences, Inc. | 1.45B | 0.03% | 1,065,943 | 746.16M |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.45B | -0.09% | 722,604 | 1.86B |
| 311 | CERT | Certara, Inc. | 1.44B | 0.85% | 1,504,632 | 421.75M |
| 312 | KRSA | Korsana Biosciences, Inc. | 1.43B | -3.00% | 346,087 | - |
| 313 | PNTG | The Pennant Group, Inc. | 1.42B | -2.89% | 279,865 | 1.10B |
| 314 | ETON | Eton Pharmaceuticals, Inc. | 1.41B | -2.17% | 375,806 | 105.60M |
| 315 | AAPG | Ascentage Pharma Group International | 1.39B | -0.07% | 3,827 | 94.61M |
| 316 | OCUL | Ocular Therapeutix, Inc. | 1.38B | -8.44% | 8,357,626 | 52.06M |
| 317 | CNMD | CONMED Corporation | 1.38B | -1.43% | 342,337 | 1.37B |
| 318 | RAPP | Rapport Therapeutics, Inc. | 1.37B | 3.74% | 300,233 | 20.00M |
| 319 | FRNM | Freenome, Inc. | 1.35B | 6.98% | 649,252 | 35.41M |
| 320 | TYRA | Tyra Biosciences, Inc. | 1.33B | 4.43% | 871,842 | - |
| 321 | INBX | Inhibrx Biosciences, Inc. | 1.32B | -0.18% | 156,055 | 1.30M |
| 322 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | 3.00% | 1,184,005 | - |
| 323 | NUTX | Nutex Health Inc. | 1.31B | 2.77% | 79,702 | 846.72M |
| 324 | TRAX | First Tracks Biotherapeutics, Inc. | 1.30B | 5.28% | 1,434,177 | - |
| 325 | TSHA | Taysha Gene Therapies, Inc. | 1.28B | 8.84% | 5,816,966 | 5.49M |
| 326 | GHRS | GH Research PLC | 1.25B | 0.72% | 323,085 | - |
| 327 | USPH | U.S. Physical Therapy, Inc. | 1.25B | -2.10% | 133,432 | 804.27M |
| 328 | LBRX | LB Pharmaceuticals Inc | 1.25B | 5.63% | 588,517 | - |
| 329 | NKTR | Nektar Therapeutics | 1.25B | 2.40% | 826,499 | 54.59M |
| 330 | INNV | InnovAge Holding Corp. | 1.21B | 0.34% | 288,783 | 989.71M |
| 331 | KARD | Kardigan, Inc. | 1.21B | -0.69% | 622,071 | - |
| 332 | CRON | Cronos Group Inc. | 1.21B | 1.25% | 788,251 | 179.09M |
| 333 | OPK | OPKO Health, Inc. | 1.20B | 5.23% | 4,014,862 | 587.90M |
| 334 | DMRA | Damora Therapeutics, Inc. | 1.19B | 4.50% | 293,161 | - |
| 335 | OMER | Omeros Corporation | 1.18B | 0.93% | 1,382,777 | 38.42M |
| 336 | SLN | Silence Therapeutics plc | 1.18B | 125.58% | 71,965,890 | 615.00K |
| 337 | SVRA | Savara Inc. | 1.18B | 4.04% | 1,563,950 | - |
| 338 | SNDX | Syndax Pharmaceuticals, Inc. | 1.17B | 1.47% | 2,192,127 | 252.25M |
| 339 | DRTS | Alpha Tau Medical Ltd. | 1.17B | 2.69% | 688,367 | - |
| 340 | BCAX | Bicara Therapeutics Inc. | 1.16B | 4.11% | 864,737 | - |
| 341 | GDRX | GoodRx Holdings, Inc. | 1.15B | 0.30% | 977,536 | 785.23M |
| 342 | ENOV | Enovis Corporation | 1.15B | 1.43% | 1,616,608 | 2.30B |
| 343 | TNDM | Tandem Diabetes Care, Inc. | 1.14B | 0.86% | 1,272,330 | 1.04B |
| 344 | AHG | Akso Health Group | 1.14B | -1.48% | 1,930 | 13.83M |
| 345 | BVS | Bioventus Inc. | 1.13B | 1.43% | 409,517 | 581.85M |
| 346 | IRMD | IRADIMED CORPORATION | 1.12B | -0.70% | 78,855 | 86.34M |
| 347 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.11B | 1.01% | 299,509 | 730.02M |
| 348 | OMDA | Omada Health, Inc. | 1.11B | 2.44% | 744,794 | 309.76M |
| 349 | STAA | STAAR Surgical Company | 1.10B | 2.87% | 680,341 | 339.59M |
| 350 | AORT | Artivion, Inc. | 1.09B | 2.30% | 465,119 | 471.47M |
| 351 | NBTX | Nanobiotix S.A. | 1.07B | 0.56% | 44,335 | 13.15M |
| 352 | VOR | Vor Biopharma Inc. | 1.07B | 0.11% | 724,811 | - |
| 353 | CTY | City Therapeutics, Inc. | 1.07B | -4.20% | 299,344 | 14.34M |
| 354 | VSTM | Verastem, Inc. | 1.05B | -0.35% | 3,398,167 | 87.53M |
| 355 | PRCT | PROCEPT BioRobotics Corporation | 1.05B | 4.04% | 1,011,831 | 337.34M |
| 356 | IART | Integra LifeSciences Holdings Corporation | 1.05B | 1.82% | 726,129 | 1.65B |
| 357 | REPL | Replimune Group, Inc. | 1.04B | 1.75% | 1,539,617 | - |
| 358 | TDOC | Teladoc Health, Inc. | 1.04B | 1.06% | 2,679,938 | 2.49B |
| 359 | HROW | Harrow, Inc. | 1.04B | 1.47% | 576,127 | 275.59M |
| 360 | AVLN | Avalyn Pharma Inc. | 1.03B | -1.39% | 179,885 | - |
| 361 | LMRI | Lumexa Imaging Holdings, Inc. | 1.03B | -0.56% | 277,662 | 1.04B |
| 362 | JANX | Janux Therapeutics, Inc. | 1.02B | 1.39% | 915,058 | 24.00M |
| 363 | HSTM | HealthStream, Inc. | 1.02B | 0.54% | 172,059 | 321.12M |
| 364 | CBLL | CeriBell, Inc. | 997.83M | 3.83% | 633,499 | 101.96M |
| 365 | MNKD | MannKind Corporation | 993.56M | 1.64% | 2,457,386 | 393.63M |
| 366 | CSTL | Castle Biosciences, Inc. | 982.62M | 0.64% | 347,231 | 357.28M |
| 367 | IMTX | Immatics N.V. | 963.66M | 4.75% | 966,126 | 47.65M |
| 368 | SPTX | Seaport Therapeutics, Inc. | 952.31M | -0.22% | 145,729 | - |
| 369 | LTGO | Latigo Biotherapeutics, Inc. | 948.08M | 2.14% | 283,831 | - |
| 370 | GLUE | Monte Rosa Therapeutics, Inc. | 909.44M | 9.45% | 1,925,832 | 28.73M |
| 371 | MGTX | MeiraGTx Holdings plc | 907.61M | 1.83% | 759,482 | 397.50M |
| 372 | CGEM | Cullinan Therapeutics, Inc. | 899.68M | 8.12% | 862,337 | - |
| 373 | ANRO | Alto Neuroscience, Inc. | 895.50M | 4.01% | 681,860 | - |
| 374 | BBNX | Beta Bionics, Inc. | 886.49M | 3.00% | 1,684,844 | 119.01M |
| 375 | AVBP | ArriVent BioPharma, Inc. | 884.58M | 7.68% | 1,013,138 | - |
| 376 | SIBN | SI-BONE, Inc. | 881.13M | -0.10% | 338,144 | 213.60M |
| 377 | JBIO | Jade Biosciences, Inc. | 879.55M | 2.67% | 826,789 | - |
| 378 | QDEL | QuidelOrtho Corporation | 875.02M | -1.16% | 1,425,141 | 2.67B |
| 379 | RIGL | Rigel Pharmaceuticals, Inc. | 872.72M | 1.63% | 318,413 | 276.79M |
| 380 | SLBT | SL Science Holding Limited | 872.51M | - | 12,683 | 3.27M |
| 381 | ODTX | Odyssey Therapeutics, Inc. | 867.32M | 5.42% | 300,336 | 99.00K |
| 382 | AKTS | Aktis Oncology, Inc. | 841.52M | 0.46% | 353,421 | 10.06M |
| 383 | ABUS | Arbutus Biopharma Corporation | 836.90M | 0.24% | 1,959,257 | 181.72M |
| 384 | KURA | Kura Oncology, Inc. | 832.67M | 3.08% | 2,158,291 | 77.23M |
| 385 | MLTX | MoonLake Immunotherapeutics | 829.79M | 2.09% | 911,118 | - |
| 386 | SGP | SpyGlass Pharma, Inc. | 822.82M | 2.50% | 69,780 | - |
| 387 | ALMS | Alumis Inc. | 820.62M | 3.59% | 1,483,616 | 7.40M |
| 388 | CRVS | Corvus Pharmaceuticals, Inc. | 811.77M | 1.37% | 814,642 | - |
| 389 | INMD | InMode Ltd. | 808.75M | -0.64% | 399,678 | 374.63M |
| 390 | AHCO | AdaptHealth Corp. | 784.45M | -2.33% | 3,432,327 | 3.36B |
| 391 | HELP | Helus Pharma Inc. | 781.01M | 1.33% | 975,254 | - |
| 392 | GMRS | GMR Solutions Inc. | 775.66M | -0.20% | 371,528 | 5.88B |
| 393 | VREX | Varex Imaging Corporation | 775.52M | -0.05% | 544,201 | 865.00M |
| 394 | IAM | Iambic Therapeutics, Inc. | 774.53M | -31.37% | 2,377,903 | 18.25M |
| 395 | GERN | Geron Corporation | 770.97M | 2.56% | 4,909,349 | 204.56M |
| 396 | ARDX | Ardelyx, Inc. | 769.99M | - | 3,227,243 | 450.89M |
| 397 | ANNX | Annexon, Inc. | 760.21M | 17.60% | 6,362,378 | - |
| 398 | COLL | Collegium Pharmaceutical, Inc. | 749.10M | -0.78% | 713,872 | 808.21M |
| 399 | OBX | Obsidian Therapeutics, Inc. | 737.57M | 1.44% | 106,436 | - |
| 400 | IVA | Inventiva S.A. | 717.00M | 1.36% | 3,952,579 | 2.81M |
| 401 | PHR | Phreesia, Inc. | 700.16M | 3.11% | 764,062 | 507.79M |
| 402 | APMD | Apnimed, Inc. | 690.86M | -6.56% | 264,178 | 115.12M |
| 403 | LXRX | Lexicon Pharmaceuticals, Inc. | 689.68M | 1.97% | 1,723,445 | 41.47M |
| 404 | SANA | Sana Biotechnology, Inc. | 688.53M | 1.32% | 2,625,695 | - |
| 405 | CTKB | Cytek Biosciences, Inc. | 682.41M | - | 700,524 | 206.71M |
| 406 | OABI | OmniAb, Inc. | 681.88M | 2.18% | 892,404 | 38.46M |
| 407 | IMMX | Immix Biopharma, Inc. | 681.46M | 3.01% | 1,302,390 | - |
| 408 | PRME | Prime Medicine, Inc. | 681.37M | 10.37% | 4,250,299 | 4.07M |
| 409 | ACHV | Achieve Life Sciences, Inc. | 679.67M | 3.53% | 823,321 | - |
| 410 | FDMT | 4D Molecular Therapeutics, Inc. | 678.95M | 1.28% | 855,676 | 92.01M |
| 411 | DNA | Ginkgo Bioworks Holdings, Inc. | 678.12M | -1.95% | 2,475,430 | 132.42M |
| 412 | ANL | Adlai Nortye Group Ltd. | 668.45M | -5.89% | 356,327 | 18.06M |
| 413 | DSGN | Design Therapeutics, Inc. | 665.87M | 3.20% | 359,186 | - |
| 414 | STLN | Starling Oncology, Inc. | 658.38M | 0.47% | 982,653 | 587.24M |
| 415 | AURA | Aura Biosciences, Inc. | 652.30M | 3.11% | 556,344 | - |
| 416 | PHAR | Pharming Group N.V. | 647.85M | -2.67% | 13,256 | 366.48M |
| 417 | GYRE | Gyre Therapeutics, Inc. | 645.75M | 0.16% | 119,928 | 109.82M |
| 418 | MDXG | MiMedx Group, Inc. | 638.43M | -1.13% | 2,686,789 | 355.17M |
| 419 | SLDB | Solid Biosciences Inc. | 634.77M | 7.05% | 1,847,796 | - |
| 420 | ATTO | Attovia Therapeutics, Inc. | 632.73M | 0.95% | 297,535 | 1.80M |
| 421 | SGMT | Sagimet Biosciences Inc. | 628.25M | 10.47% | 1,684,863 | - |
| 422 | CADL | Candel Therapeutics, Inc. | 628.22M | 0.24% | 1,278,692 | - |
| 423 | WVE | Wave Life Sciences, Inc. | 624.64M | 1.28% | 1,867,558 | 65.37M |
| 424 | OLMA | Olema Pharmaceuticals, Inc. | 622.11M | 8.05% | 1,271,973 | - |
| 425 | AVTX | Avalo Therapeutics, Inc. | 621.57M | 2.84% | 2,221,802 | 59.00K |
| 426 | NVCT | Nuvectis Pharma, Inc. | 617.09M | 1.83% | 198,177 | - |
| 427 | ZVRA | Zevra Therapeutics, Inc. | 603.34M | 2.21% | 719,611 | 136.07M |
| 428 | AVR | Anteris Technologies Global Corp. | 602.51M | 2.15% | 1,358,787 | 2.24M |
| 429 | WEAV | Weave Communications, Inc. | 591.99M | - | 600,587 | 257.79M |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 588.25M | 1.71% | 1,677,201 | 389.32M |
| 431 | CRMD | CorMedix Inc. | 575.23M | 1.65% | 1,472,361 | 462.25M |
| 432 | KIDS | OrthoPediatrics Corp. | 575.20M | 0.36% | 209,138 | 252.72M |
| 433 | PACB | Pacific Biosciences of California, Inc. | 571.93M | 6.36% | 6,034,785 | 159.27M |
| 434 | CLYM | Climb Bio, Inc. | 558.85M | -0.92% | 1,209,412 | - |
| 435 | PHAT | Phathom Pharmaceuticals, Inc. | 556.80M | 1.30% | 1,017,108 | 239.66M |
| 436 | FLGT | Fulgent Genetics, Inc. | 553.06M | 1.46% | 212,713 | 323.93M |
| 437 | SOPH | SOPHiA GENETICS SA | 552.48M | -3.57% | 510,904 | 86.17M |
| 438 | ETRA | Electra Therapeutics, Inc. | 542.93M | -1.14% | 308,986 | - |
| 439 | STTK | Shattuck Labs, Inc. | 538.95M | -0.92% | 869,584 | 1.00M |
| 440 | DBVT | DBV Technologies S.A. | 530.92M | -0.55% | 269,540 | 5.04M |
| 441 | CBIO | Crescent Biopharma, Inc. | 529.02M | 4.56% | 230,691 | 11.88M |
| 442 | EVO | Evotec SE | 528.13M | 3.62% | 77,557 | 819.47M |
| 443 | PBYI | Puma Biotechnology, Inc. | 527.04M | 3.87% | 459,836 | 231.24M |
| 444 | DRUG | Bright Minds Biosciences Inc. | 521.97M | 4.91% | 156,303 | - |
| 445 | VALN | Valneva SE | 515.28M | -1.78% | 9,143 | 163.30M |
| 446 | TCMD | Tactile Systems Technology, Inc. | 515.11M | 0.98% | 165,214 | 350.31M |
| 447 | ACRS | Aclaris Therapeutics, Inc. | 512.25M | 6.10% | 1,747,401 | 8.22M |
| 448 | ENTX | Entera Bio Ltd. | 511.33M | 9.70% | 953,135 | 42.00K |
| 449 | CTMX | CytomX Therapeutics, Inc. | 509.88M | 2.63% | 2,046,848 | 18.30M |
| 450 | EVH | Evolent Health, Inc. | 506.51M | -1.97% | 1,636,209 | 2.10B |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 4.81M |
| 452 | FTH | Faeth Therapeutics, Inc. | 502.34M | 3.40% | 350,610 | - |
| 453 | DCTH | Delcath Systems, Inc. | 498.62M | 2.06% | 300,137 | 95.42M |
| 454 | EOLS | Evolus, Inc. | 486.13M | 3.66% | 517,871 | 316.49M |
| 455 | NGNE | Neurogene Inc. | 483.68M | 3.96% | 240,155 | 925.00K |
| 456 | BWAY | BrainsWay Ltd. | 482.77M | 4.81% | 108,948 | 60.70M |
| 457 | SSII | SS Innovations International, Inc. | 480.93M | -5.14% | 100,240 | 52.40M |
| 458 | AQST | Aquestive Therapeutics, Inc. | 480.71M | 1.32% | 3,335,336 | 54.09M |
| 459 | MNPR | Monopar Therapeutics Inc. | 479.72M | 3.18% | 73,776 | - |
| 460 | ANGO | AngioDynamics, Inc. | 479.00M | 1.33% | 875,477 | 325.38M |
| 461 | ARVN | Arvinas, Inc. | 474.70M | 4.16% | 795,634 | 316.70M |
| 462 | MASS | 908 Devices Inc. | 472.44M | 1.51% | 309,211 | 60.84M |
| 463 | RGNX | REGENXBIO Inc. | 471.99M | 3.17% | 1,297,965 | 174.48M |
| 464 | EPRX | Eupraxia Pharmaceuticals Inc. | 459.86M | 4.98% | 398,524 | - |
| 465 | SGHT | Sight Sciences, Inc. | 455.03M | -0.24% | 186,108 | 83.38M |
| 466 | NRC | NRC Health | 452.79M | 1.59% | 68,412 | 140.00M |
| 467 | BLSM | BlossomHill Therapeutics, Inc. | 451.98M | 2.01% | 189,366 | - |
| 468 | OCS | Oculis Holding AG | 451.88M | 0.41% | 288,241 | 1.45M |
| 469 | ALLO | Allogene Therapeutics, Inc. | 449.14M | -0.76% | 5,905,023 | 4.64M |
| 470 | CERS | Cerus Corporation | 447.39M | 1.83% | 1,570,397 | 221.55M |
| 471 | MPLT | MapLight Therapeutics, Inc. | 444.61M | 3.90% | 278,655 | - |
| 472 | TLRY | Tilray Brands, Inc. | 444.39M | -0.33% | 2,556,019 | 963.10M |
| 473 | KMDA | Kamada Ltd. | 440.15M | -1.93% | 49,104 | 191.85M |
| 474 | NPCE | NeuroPace, Inc. | 438.32M | 4.33% | 117,383 | 106.99M |
| 475 | PRTA | Prothena Corporation plc | 435.34M | 1.56% | 361,132 | 54.53M |
| 476 | ALT | Altimmune, Inc. | 433.77M | 1.36% | 2,609,702 | 31.00K |
| 477 | YDES | YD Bio Limited | 433.49M | 3.38% | 92,518 | 1.24M |
| 478 | DMAC | DiaMedica Therapeutics Inc. | 424.40M | 3.96% | 188,583 | - |
| 479 | OVID | Ovid Therapeutics Inc. | 423.80M | 0.93% | 1,640,687 | 1.58M |
| 480 | SENS | Senseonics Holdings, Inc. | 423.79M | 3.15% | 417,786 | 48.55M |
| 481 | AUTL | Autolus Therapeutics plc | 423.20M | -0.63% | 1,522,120 | 117.39M |
| 482 | PROK | ProKidney Corp. | 421.74M | 4.89% | 966,827 | 818.00K |
| 483 | SPRY | ARS Pharmaceuticals, Inc. | 420.66M | 5.22% | 1,509,041 | 116.93M |
| 484 | EIKN | Eikon Therapeutics, Inc. | 417.07M | 3.77% | 701,600 | - |
| 485 | TECX | Tectonic Therapeutic, Inc. | 413.47M | 2.42% | 202,963 | - |
| 486 | ASMB | Assembly Biosciences, Inc. | 410.78M | 0.42% | 199,155 | 74.85M |
| 487 | RCEL | AVITA Medical, Inc. | 406.38M | 0.77% | 267,121 | 75.63M |
| 488 | AGMB | AgomAb Therapeutics NV | 405.31M | -0.60% | 34,844 | - |
| 489 | MYGN | Myriad Genetics, Inc. | 402.69M | 5.78% | 1,355,834 | 806.60M |
| 490 | SRTA | Strata Critical Medical, Inc. | 401.64M | - | 1,442,318 | 255.98M |
| 491 | TRXB | TRex Bio, Inc. | 398.45M | 5.64% | 113,273 | - |
| 492 | AUNA | Auna S.A. | 398.19M | 1.13% | 174,484 | 1.37B |
| 493 | OFIX | Orthofix Medical Inc. | 390.63M | 2.24% | 296,086 | 833.19M |
| 494 | RZLT | Rezolute, Inc. | 388.12M | 3.35% | 1,778,337 | - |
| 495 | CAPR | Capricor Therapeutics, Inc. | 386.62M | -0.89% | 1,911,226 | 11.13M |
| 496 | SI | Shoulder Innovations, Inc. | 379.95M | 0.88% | 67,797 | 60.06M |
| 497 | CYH | Community Health Systems, Inc. | 374.06M | -4.17% | 901,181 | 11.98B |
| 498 | CARL | Carlsmed, Inc. | 372.96M | 1.86% | 55,653 | 63.30M |
| 499 | CTEV | Claritev Corporation | 372.17M | -0.72% | 109,942 | 994.67M |
| 500 | EDIT | Editas Medicine, Inc. | 371.66M | 2.98% | 2,010,880 | 47.01M |